IGF2 and fibroblastic neoplasm: Non–islet cell tumor hypoglycemia (NICTH) as a result of insulin-like growth factor-2 (IGF-2) secretion is rare, most commonly seen in tumors of mesenchymal origin, particularly fibrous tumors, and to a lesser degree, tumors of epithelial origin [1, 2].